GlassScriptPhysician profile
Eden Rabban
NPI 1639948805
$1,032.26
in general payments reported to CMS, 2019-2025
20 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $712 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $219.23 | 2024-2025 | Austedo Xr, Austedo Xr |
| Abbvie INC. | $141.81 | 2024-2025 | |
| Atricure, INC. | $112.77 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Novartis Pharmaceuticals Corporation | $105.66 | 2024-2025 | |
| Argenx US, INC. | $86.45 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Ipsen Biopharmaceuticals, INC | $60.00 | 2024-2025 | Dysport |
| Kyowa Kirin, INC. | $42.52 | 2024 | Nourianz |
| Pfizer INC. | $37.03 | 2024 | |
| Neurelis, INC. | $29.80 | 2024 | Valtoco |
| Shockwave Medical, INC | $28.96 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Eisai INC. | $23.48 | 2025 | |
| Celgene Corporation | $18.96 | 2024 | Zeposia |
| Lundbeck LLC | $17.00 | 2024 | Vyepti |
| Harmony Biosciences LLC | $16.91 | 2024 | |
| Life Molecular Imaging LTD | $16.88 | 2024 | Neuraceq |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $16.39 | 2025 | |
| Alexion Pharmaceuticals, INC. | $16.29 | 2025 | Ultomiris |
| Lilly USA, LLC | $15.28 | 2024 | Emgality |
| Astrazeneca Pharmaceuticals LP | $14.83 | 2025 | Wainua |
| Aucta Pharmaceuticals, INC. | $12.01 | 2024 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eden Rabban listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.